144 related articles for article (PubMed ID: 3383775)
1. Molecular effects of antiestrogens (tamoxifen and LY117018) on estrogen-dependent glycoprotein (USP-1) synthesized and secreted by rat uterine epithelial cells.
Takeda A; Shimizu S
Endocrinology; 1988 Jul; 123(1):258-63. PubMed ID: 3383775
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of an estrogen-inducible glycoprotein (uterine secretory protein-1) synthesized and secreted by rat uterine epithelial cells.
Takeda A; Takahashi N; Shimizu S
Endocrinology; 1988 Jan; 122(1):105-13. PubMed ID: 3275533
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018.
Jordan VC; Gosden B
Endocrinology; 1983 Aug; 113(2):463-8. PubMed ID: 6872937
[TBL] [Abstract][Full Text] [Related]
4. Evidence for biological action of the antiestrogens LY117018 and tamoxifen by different mechanisms.
Black LJ; Goode RL
Endocrinology; 1981 Sep; 109(3):987-9. PubMed ID: 7262030
[TBL] [Abstract][Full Text] [Related]
5. Differential antiestrogen action in the immature rat uterus: a comparison of hydroxylated antiestrogens with high affinity for the estrogen receptor.
Jordan VC; Gosden B
J Steroid Biochem; 1983 Sep; 19(3):1249-58. PubMed ID: 6684713
[TBL] [Abstract][Full Text] [Related]
6. The stimulation of uterine complement component C3 gene expression by antiestrogens.
Sundstrom SA; Komm BS; Xu Q; Boundy V; Lyttle CR
Endocrinology; 1990 Mar; 126(3):1449-56. PubMed ID: 2307112
[TBL] [Abstract][Full Text] [Related]
7. Progesterone and antiprogesterone (RU 38486) modulation of estrogen-inducible glycoprotein (USP-1) synthesis and secretion in rat uterine epithelial cells.
Takeda A
Endocrinology; 1988 Apr; 122(4):1559-64. PubMed ID: 3345728
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of estrogen- and antiestrogen-induced uterine complement component C3 expression by ICI 164,384.
Galman MS; Sundstrom SA; Lyttle CR
J Steroid Biochem; 1990 Jul; 36(4):281-6. PubMed ID: 2391957
[TBL] [Abstract][Full Text] [Related]
9. Opposing biological actions of antiestrogens in vitro and in vivo: induction of progesterone receptor in the rat and mouse uterus.
Campen CA; Jordan VC; Gorski J
Endocrinology; 1985 Jun; 116(6):2327-36. PubMed ID: 3996316
[TBL] [Abstract][Full Text] [Related]
10. Antiestrogen stimulation of the production of a 37,000 molecular weight secreted protein and estrogen stimulation of the production of a 32,000 molecular weight secreted protein in MCF-7 human breast cancer cells.
Sheen YY; Katzenellenbogen BS
Endocrinology; 1987 Mar; 120(3):1140-51. PubMed ID: 3803313
[TBL] [Abstract][Full Text] [Related]
11. Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice.
Black LJ; Goode RL
Life Sci; 1980 Apr; 26(17):1453-8. PubMed ID: 7382727
[No Abstract] [Full Text] [Related]
12. Tamoxifen and the Rafoxifene analog LY117018: their effects on arachidonic acid release from cells in culture and on prostaglandin I2 production by rat liver cells.
Levine L
BMC Cancer; 2004 Aug; 4():49. PubMed ID: 15310397
[TBL] [Abstract][Full Text] [Related]
13. Counteraction of estradiol-induced activation of tissue-type plasminogen activator in a human breast cancer cell line by an anti-estrogen, LY117018.
Uchiumi T; Mizoguchi H; Hagino Y; Kohno K; Kuwano M
Int J Cancer; 1991 Jan; 47(1):80-5. PubMed ID: 1702405
[TBL] [Abstract][Full Text] [Related]
14. Modulation of rat uterine progesterone receptor levels and peroxidase activity by tamoxifen citrate, LY117018, and estradiol.
Keeping HS; Lyttle CR
Endocrinology; 1982 Dec; 111(6):2046-54. PubMed ID: 6890442
[No Abstract] [Full Text] [Related]
15. Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists.
Kraus WL; Katzenellenbogen BS
Endocrinology; 1993 Jun; 132(6):2371-9. PubMed ID: 8504742
[TBL] [Abstract][Full Text] [Related]
16. Differential interaction of antiestrogens with cytosol estrogen receptors.
Black LJ; Jones CD; Goode RL
Mol Cell Endocrinol; 1981 Apr; 22(1):95-103. PubMed ID: 7239000
[TBL] [Abstract][Full Text] [Related]
17. The antiestrogen LY117018 blocks effects of estradiol on pituitary glucose-6-phosphate dehydrogenase specific activity and on serum LH.
Gordon MN; Mobbs CV; Finch CE
Neuroendocrinology; 1985 May; 40(5):381-4. PubMed ID: 4010886
[TBL] [Abstract][Full Text] [Related]
18. Morphologic effects of epithelial ion channels on the mouse uterus: differences between raloxifene analog (LY117018) and estradiol treatments.
Nobuzane T; Tashiro S; Kudo Y
Am J Obstet Gynecol; 2008 Oct; 199(4):363.e1-6. PubMed ID: 18456231
[TBL] [Abstract][Full Text] [Related]
19. The antiestrogen LY117018 is estrogenic in the fetal rat.
Henry EC; Miller RK
Teratology; 1986 Aug; 34(1):59-63. PubMed ID: 3764778
[TBL] [Abstract][Full Text] [Related]
20. Antiestrogens are partial estrogen agonists for prolactin production in primary pituitary cultures.
Martinez-Campos A; Amara JF; Dannies PS
Mol Cell Endocrinol; 1986 Dec; 48(2-3):127-33. PubMed ID: 3803705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
